Not finding it? Sign in to also search OpenAlex live.
-
Data from Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors
Giuseppe Curigliano, Hans A. J. Gelderblom, Nicolas Mach, Toshihiko Doi, David Wai-Meng Tai, Patrick M. Forde, +13 more
0citations -
Data from Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors
Giuseppe Curigliano, Hans A. J. Gelderblom, Nicolas Mach, Toshihiko Doi, David Wai-Meng Tai, Patrick M. Forde, +13 more
0citations -
The EHA Research Roadmap: Hematopoietic Stem Cells and Allotransplantation.2022 Apollo (University of Cambridge) other Medicine Hematopoietic Stem Cell Transplantation Open access
Willem E. Fibbe, Rosa Bernardi, Pierre Charbord, Daniela S. Krause, Cristina Lo Celso, Simón Méndez‐Ferrer, +6 more
1citations
10 results